Use of pdev inhibitors for improved fecundity in mammals

Details Use of pdev inhibitors for improved fecundity in mammals Use of pdev inhibitors for improved fecundity in mammals

A - Human Necessities

61

K

A61K 31/519 (2006.01) A61K 31/404 (2006.01) A61K 31/431 (2006.01) A61K 31/4985 (2006.01) A61K 31/501 (2006.01) A61K 31/502 (2006.01) A61K 31/505 (2006.01) A61K 31/517 (2006.01) A61K 31/52 (2006.01) A61K 31/522 (2006.01) A61K 31/53 (2006.01) A61K 31/5377 (2006.01) A61P 15/08 (2006.01)

Patent

CA 2359383

The invention relates to the use of a cyclic guanosine 3', 5'-monophosphate phosphodiesterase type five (cGMP PDE V) inhibitor for increasing fecundity in a mammal by one or more of (a) promoting the growth of an oocyte, zygote, blastocyst, embryo and/or foetus, (b) increasing the rate or probability of survival of an embryo and/or foetus and (c) increasing the birth weight of a progeny, or for increasing milk productivity.

Affiliated with

Also associated with

Rating

Use of pdev inhibitors for improved fecundity in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pdev inhibitors for improved fecundity in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pdev inhibitors for improved fecundity in mammals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1920123